Skillman, NJ, United States of America

Jennifer Callaghan

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Johnson & Johnson Consumer Inc., Kenvue Brands LLC. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Callaghan. Retrieved from https://idiyas.com/inventor/jennifer-callaghan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jennifer Callaghan: A Focus on Allergy Management

Introduction

Jennifer Callaghan is an accomplished inventor based in Skillman, NJ (US). She has made significant contributions to the field of allergy management through her innovative approach to understanding and mitigating allergen symptoms. With a keen focus on personalized treatment, her work aims to improve the quality of life for individuals suffering from allergies.

Latest Patents

Jennifer holds a patent for a groundbreaking method titled "Method to mitigate allergen symptoms in a personalized and hyperlocal manner." This patent describes a system and method for determining an allergy impact profile of an individual. The technology predicts how environmental conditions may affect allergy symptoms and recommends tailored treatments based on the predicted allergy impact. This innovative approach represents a significant advancement in allergy management.

Career Highlights

Jennifer Callaghan is currently employed at Johnson & Johnson Consumer Inc., where she continues to develop solutions that address consumer health challenges. Her work is characterized by a commitment to research and innovation, which has led to her successful patent.

Collaborations

Jennifer collaborates with notable colleagues, including Russell Gould and Russel M Walters. Their combined expertise enhances the development of effective solutions in the field of allergy management.

Conclusion

Jennifer Callaghan's contributions to allergy management through her innovative patent demonstrate her dedication to improving individual health outcomes. Her work at Johnson & Johnson Consumer Inc. continues to pave the way for advancements in personalized healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…